Literature DB >> 29273304

Redundancy and robustness versus division of labour and specialization in innate immunity.

Alberto Mantovani1.   

Abstract

Apparent redundancy is a recurrent theme in innate immunity in various domains including inflammatory cytokines, chemokines and pattern recognition receptors. While sharing core function, different mediators may subserve distinct functions related for instance to production and release (e.g. IL-1α versus IL-1β), predominantly local versus systemic function (e.g. PTX3 versus C-reactive protein) or fine tuning of innate and adaptive responses (chemokines). Based on hard-wired phagocyte recruitment and regulation by a wide spectrum of chemokines and conventional or atypical receptors, I argue that trafficking of phagocytic cells is a robust output of the chemokine system, resistant to genetic or environmental variation. In general, I speculate that the apparent overlap and redundancy observed in core functions represents an evolutionary strategy to preserve robust essential core outputs in the face of genetically or environmentally caused variation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemokines; Cytokines; Inflammation; Innate immunity; Macrophages; Neutrophils; Phagocytes; Tissue repair

Mesh:

Substances:

Year:  2017        PMID: 29273304      PMCID: PMC5923876          DOI: 10.1016/j.smim.2017.12.006

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   10.671


  22 in total

1.  Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues.

Authors:  Astrid E Cardona; Margaret E Sasse; Liping Liu; Sandra M Cardona; Makiko Mizutani; Carine Savarin; Taofang Hu; Richard M Ransohoff
Journal:  Blood       Date:  2008-03-17       Impact factor: 22.113

Review 2.  The interleukin-1 family: back to the future.

Authors:  Cecilia Garlanda; Charles A Dinarello; Alberto Mantovani
Journal:  Immunity       Date:  2013-12-12       Impact factor: 31.745

Review 3.  An integrated view of humoral innate immunity: pentraxins as a paradigm.

Authors:  Barbara Bottazzi; Andrea Doni; Cecilia Garlanda; Alberto Mantovani
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

Review 4.  Chemokines and chemokine receptors: positioning cells for host defense and immunity.

Authors:  Jason W Griffith; Caroline L Sokol; Andrew D Luster
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

5.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Authors:  Paul M Ridker; Brendan M Everett; Tom Thuren; Jean G MacFadyen; William H Chang; Christie Ballantyne; Francisco Fonseca; Jose Nicolau; Wolfgang Koenig; Stefan D Anker; John J P Kastelein; Jan H Cornel; Prem Pais; Daniel Pella; Jacques Genest; Renata Cifkova; Alberto Lorenzatti; Tamas Forster; Zhanna Kobalava; Luminita Vida-Simiti; Marcus Flather; Hiroaki Shimokawa; Hisao Ogawa; Mikael Dellborg; Paulo R F Rossi; Roland P T Troquay; Peter Libby; Robert J Glynn
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

Review 6.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

7.  IL-1 family nomenclature.

Authors:  Charles Dinarello; William Arend; John Sims; Dirk Smith; Hal Blumberg; Luke O'Neill; Raphaela Goldbach-Mansky; Theresa Pizarro; H Hoffman; Philip Bufler; Marcel Nold; Pietro Ghezzi; Alberto Mantovani; Cecilia Garlanda; Diana Boraschi; Anna Rubartelli; Mihai Netea; Jos van der Meer; Leo Joosten; Tom Mandrup-Poulsen; Marc Donath; Eli Lewis; Josef Pfeilschifter; Michael Martin; Michael Kracht; H Muehl; Daniela Novick; Miodrag Lukic; Bruno Conti; Alan Solinger; Peyman Kelk; Kelk Peyman; Frank van de Veerdonk; Chiristopher Gabel
Journal:  Nat Immunol       Date:  2010-11       Impact factor: 25.606

Review 8.  The biochemistry and biology of the atypical chemokine receptors.

Authors:  G J Graham; M Locati; A Mantovani; A Rot; M Thelen
Journal:  Immunol Lett       Date:  2012-07-30       Impact factor: 3.685

9.  Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.

Authors:  Paul M Ridker; Jean G MacFadyen; Tom Thuren; Brendan M Everett; Peter Libby; Robert J Glynn
Journal:  Lancet       Date:  2017-08-27       Impact factor: 79.321

10.  Atypical chemokine receptor 1 on nucleated erythroid cells regulates hematopoiesis.

Authors:  Johan Duchene; Igor Novitzky-Basso; Aude Thiriot; Maria Casanova-Acebes; Mariaelvy Bianchini; S Leah Etheridge; Elin Hub; Katrin Nitz; Katharina Artinger; Kathrin Eller; Jorge Caamaño; Thomas Rülicke; Paul Moss; Remco T A Megens; Ulrich H von Andrian; Andres Hidalgo; Christian Weber; Antal Rot
Journal:  Nat Immunol       Date:  2017-05-29       Impact factor: 25.606

View more
  7 in total

Review 1.  Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity.

Authors:  Alberto Mantovani; Charles A Dinarello; Martina Molgora; Cecilia Garlanda
Journal:  Immunity       Date:  2019-04-16       Impact factor: 31.745

Review 2.  From fever to immunity: A new role for IGFBP-6?

Authors:  Arcangelo Liso; Nazzareno Capitanio; Roberto Gerli; Massimo Conese
Journal:  J Cell Mol Med       Date:  2018-08-17       Impact factor: 5.310

Review 3.  Concepts of GPCR-controlled navigation in the immune system.

Authors:  Tim Lämmermann; Wolfgang Kastenmüller
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

4.  Engineered anti-inflammatory peptides inspired by mapping an evasin-chemokine interaction.

Authors:  Benoit Darlot; James R O Eaton; Lucia Geis-Asteggiante; Gopala K Yakala; Kalimuthu Karuppanan; Graham Davies; Carol V Robinson; Akane Kawamura; Shoumo Bhattacharya
Journal:  J Biol Chem       Date:  2020-05-29       Impact factor: 5.157

5.  CD47 expression and CD163+ macrophages correlated with prognosis of pancreatic neuroendocrine tumor.

Authors:  Rami Imam; Qing Chang; Margaret Black; Caroline Yu; Wenqing Cao
Journal:  BMC Cancer       Date:  2021-03-25       Impact factor: 4.430

6.  Phylogenetic Analysis Indicates That Evasin-Like Proteins of Ixodid Ticks Fall Into Three Distinct Classes.

Authors:  Shoumo Bhattacharya; Patricia Anne Nuttall
Journal:  Front Cell Infect Microbiol       Date:  2021-10-22       Impact factor: 5.293

Review 7.  The Long Pentraxin PTX3 in Bone Homeostasis and Pathology.

Authors:  Raffaella Parente; Cristina Sobacchi; Barbara Bottazzi; Alberto Mantovani; Danka Grčevic; Antonio Inforzato
Journal:  Front Immunol       Date:  2019-11-08       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.